Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of SYNACT PHARMA AB
No Price
Closing Price XSTO 29.04.2026:
17,80 SEK
29.04.2026 14:03
Current Prices from SYNACT PHARMA AB
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ STOCKHOLM AB
SYNACT.ST
SEK
29.04.2026 14:03
17,80 SEK
-0,06 SEK
-0,34 %
Share Float & Liquidity
Free Float62,09 %
Shares Float33,11 M
Shares Outstanding53,33 M
Company Profile for SYNACT PHARMA AB Share
SynAct Pharma AB, through its subsidiary, SynAct Pharma ApS, develops medicines for acute deterioration in inflammatory diseases. The company is developing AP1189, a drug candidate for the treatment of rheumatoid arthritis and idiopathic membranous glomerulonephritis. It has a partnership with the University Of Örebro to study the reduction of inflammation in vascular disease. The company was founded in 2012 and is headquartered in Lund, Sweden.
